Global Human Insulin Market is Projected to Reach US$ $48,488 Million by 2022

Date: 2015-12-20

Human insulin in the report refers to synthetic insulin manufactured in laboratories by growing insulin protein with the help of E. coli bacteria.

Increasing usage of insulin pens for the administration of insulin helps to inject insulin accurately. In addition, growing demand of biosimilar drugs due to its cost effectiveness is an opportunity for the growth of the market.

Human insulin market is growing moderately due to increase in prevalence of diabetic population, rise in geriatric population, rising awareness of diabetes and rising prevalence of obesity. However, strict regulatory requirements for approval of insulin and high cost of analog are inhibiting the growth of the global human insulin market.

Globally, modern human insulin has the largest market share and is also the fastest growing human insulin type. In addition, long acting human insulin has the largest market share in the modern human insulin market, and premixed human insulin is the fastest growing modern human insulin in the market. Long acting human insulin is prescribed by physicians for the treatment of type 2 diabetes. It is absorbed slowly and works for long time to control the sugar level between meal and sleep.

Human Insulin Market by Brand 


Contact With Us
Join templatemonster at google+
Customized Research
Request Sample